01 1Catalyst Pharmaceuticals
01 1SUSPENSION;ORAL
01 1RX
01 1AGAMREE
01 1USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AGAMREE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2023-10-26
Application Number : 215239
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?